P

Inventor

DEPRINCE RANDOLPH B

US13 patents
⚠️ This page may combine multiple inventors who share the name “DEPRINCE RANDOLPH B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INT MINERALS & CHEM CORP

5 patents
US4917685AApr 17, 1990

Delivery device for the administration of stabilized growth promoting hormones

INT MINERALS & CHEM CORP86 citations94
US4898733AFeb 6, 1990

Layered, compression molded device for the sustained release of a beneficial agent

INT MINERALS & CHEM CORP87 citations94
US4765980AAug 23, 1988

Stabilized porcine growth hormone

INT MINERALS & CHEM CORP103 citations94
US4663147AMay 5, 1987

Disc-like sustained release formulation

INT MINERALS & CHEM CORP48 citations92
US5008112AApr 16, 1991

Device for the extended delivery of diffusible agents

INT MINERALS & CHEM CORP24 citations91

AMGEN INC

3 patents
US5985265ANov 16, 1999

N-terminally chemically modified protein compositions and methods

AMGEN INC229 citations97
US5824784AOct 20, 1998

N-terminally chemically modified protein compositions and methods

AMGEN INC779 citations97
US7662933B2Feb 16, 2010

N-terminally chemically modified protein compositions and methods

AMGEN INC59 citations95

GLAXO GROUP LTD

2 patents
US6251864B1Jun 26, 2001

Peptides and compounds that bind to a receptor

GLAXO GROUP LTD146 citations98
US6506362B1Jan 14, 2003

Labeled compounds that bind to a thrombopoietin receptor

GLAXO GROUP LTD39 citations92

GLAXO WELLCOME INC

1 patent
US6121238ASep 19, 2000

Peptides and compounds that bind to a receptor

GLAXO WELLCOME INC57 citations95

GILEAD SCIENCES INC

1 patent
US5705693AJan 6, 1998

Cationic lipids

GILEAD SCIENCES INC16 citations78

KINSTLER OLAF B

1 patent
US8258262B2Sep 4, 2012

N-terminally chemically modified protein compositions and methods

KINSTLER OLAF B4 citations66